LVS CEO exercises 300,000 options, sells shares at ~$59 avg
Rhea-AI Filing Summary
Las Vegas Sands (LVS) reported insider activity by Chairman & CEO Robert G. Goldstein. On 10/27/2025, he exercised options for 300,000 shares of common stock at an exercise price of $34.28, then sold 35,412 shares at a weighted average price of $58.75 and 264,588 shares at a weighted average price of $59.4. Following these sales, his direct common stock holdings were 0 shares.
He reported 129,005 shares held indirectly by The Robert and Sheryl Goldstein Trust. For derivatives, the filing shows 1,700,000 options of the reported award remaining beneficially owned after the transactions, and notes the options exercised on this date were part of grants vesting in three equal annual installments beginning 12/03/2022. The remarks add that Mr. Goldstein holds 4,200,000 vested options and 403,800 unvested restricted stock units.
Positive
- None.
Negative
- None.
Insights
Form 4 shows option exercise and same-day sell-to-cover at market prices.
The reporting person exercised options for 300,000 shares at an exercise price of $34.28 and sold the resulting shares in two tranches at weighted averages of $58.75 and $59.4 on 10/27/2025. This is a classic exercise-and-sell sequence, often used to monetize vested awards.
Direct common stock holdings moved to 0 shares after the sales, while 129,005 shares remain held indirectly via a trust. The derivative table shows 1,700,000 options remaining for the reported award; the remarks state a broader inventory of 4,200,000 vested options and 403,800 unvested RSUs, indicating substantial outstanding equity incentives.
Because this is routine insider equity activity with no operational changes, the investment thesis impact is neutral. Actual market effect depends on investor interpretation of insider sales and the pace of future equity award exercises disclosed in subsequent filings.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option (Right to Buy) | 300,000 | $0.00 | -- |
| Exercise | Common Stock | 300,000 | $34.28 | $10.28M |
| Sale | Common Stock | 35,412 | $58.75 | $2.08M |
| Sale | Common Stock | 264,588 | $59.40 | $15.72M |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.20 to $59.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.20 to $59.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. These options vested in three equal annual installments beginning on December 3, 2022.
